Friday, 16 November 2018

Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

South Korea – leading biosimilars opportunities for Asia

Historically, Asia has led in generics adoption and now, with more than 300 biosimilars under development, Asia is one of the leading regions for global biosimilars development. The foundations have been laid for the biosimilar industry in Korea, providing an opportunity for the region to become a global center for manufacturing and adoption of biosimilars in the next few decades.  Just as Indian companies have carved out a leading position in the generic drug market, South Korean companies are poised to take leading positions in the biosimilars industry in the coming years.

Survey Box

Are New-Age Healthcare Consumers In Asia Embracing Technology?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls